US2012260915A1PendingUtilityA1

Nasal devices

51
Assignee: DJUPESLAND PER GISLEPriority: Jul 2, 2002Filed: Sep 25, 2011Published: Oct 18, 2012
Est. expiryJul 2, 2022(expired)· nominal 20-yr term from priority
A61M 2209/088A61M 11/00A61M 15/0021A61M 15/0051A61M 2209/06A61M 2202/04A61M 2202/30A61M 2202/064A61M 15/0098A61M 15/009A61M 15/0091A61M 15/08
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A nasal delivery device and a method of delivering substance to a nasal airway of a subject can be used for mass treatment, especially mass vaccination. The delivery device can include an interface unit, as a replaceable unit, having at least one nosepiece unit for fitting to a respective nostril of a subject, a nozzle from which substance is in use delivered, and at least one delivery unit having a substance supply unit for delivering substance to the nozzle of the at least one nosepiece unit. The delivery device can also include an actuation unit for actuating the at least one delivery unit of the interface unit.

Claims

exact text as granted — not AI-modified
1 . A nasal delivery device for delivering substance to a nasal airway of a subject, comprising: a plurality of interface units attached to a support, each interface unit comprising (i) at least one nosepiece unit for fitting to a respective nostril of a subject and comprising a nozzle from which substance is in use delivered, and (ii) at least one delivery unit comprising a substance supply unit for delivering substance to the nozzle of the at least one nosepiece unit; and an actuation unit to which the interface units are successively attached for actuating the at least one delivery unit of each respective interface unit, the actuation unit comprising an advance mechanism configured to automatically or semi-automatically advance each interface unit in turn to a position with the actuation unit, whereby the at least one delivery unit is in a position to be actuated to deliver substance to the nozzle.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.